Abstract
The use of activated macrophages in the treatment of cancer has been largely ineffectual. By ‘arming’ these cells with the ability to express a therapeutic gene we demonstrate significant advances in the efficacy of this approach. We have used a hypoxia-regulated adenoviral vector to transduce human macrophages with either a reporter or a therapeutic gene encoding human cytochrome P4502B6 (CYP2B6). Infiltration of transduced macrophages into a tumour spheroid results in induction of gene expression. We demonstrate significant tumour cell killing only in the presence of cyclophosphamide via activation by P4502B6 and show that this can be further targeted to tumours through hypoxia regulated gene expression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Normann SJ . Macrophage infiltration and tumour progression Cancer Metast Rev 1985 4: 277–291
Polverini PJ . Role of the macrophage in angiogenesis. In: Goldberg ID, Rosen EM (eds) Regulation of Angiogenesis Birkhaüser Verlag: Basel 1997 pp 11–28
Andreesen R et al. Adoptive transfer of tumour cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy Cancer Res 1990 50: 7450–7456
Jounaidi Y, Hecht JED, Waxman DJ . Retroviral transfer of cytochrome P450 genes for oxazaphosphorine-based cancer gene therapy Cancer Res 1998 58: 4391–4401
Leek RD et al. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma Cancer Res 1997 56: 4625–4629
Negus RP, Turner L, Burke F, Balkwill FR . Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumours J Leukoc Biol 1998 8: 75–88
Rockwell S, Knisely JPS . Hypoxia and angiogenesis in experimental tumour models: therapeutic implications. In: Goldberg ID, Rosen EM (eds) Regulation of Angiogenesis Birkhaüser Verlag: Basel 1997 335–360
Wenger RH, Gassman M . Oxygen(es) and the hypoxia-inducible factor-1 Biol Chem 1997 378: 609–616
Dachs GU et al. Targeting gene expression to hypoxic tumour cells Nature Med 1997 3: 515–520
Knighton DR et al. Oxygen tension regulates the expression of angiogenesis factor by macrophages Science 1983 221: 1283–1285
Scannell G et al. Hypoxia induces a human macrophage cell line to release tumour necrosis factor-alpha and its soluble receptors in vitro J Surg Res 1993 54: 281–285
Albina JE et al. Macrophage activation by culture in an anoxic environment J Immunol 1995 155: 4391–4396
Melillo G et al. Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine J Biol Chem 1997 272: 12236–12243
Harmey JH et al. Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1 Ann Surg Oncol 1998 5: 271–278
Binley K et al. An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer Gene Therapy 1999 6: 1721–1727
Sutherland RM . Cell and environment interactions in tumour microregions: the multicell spheroid model Science 1990 240: 177–184
Maxwell PH, Pugh CW, Ratcliffe PJ . Inducible operation of the erythropoietin 3′ enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism Proc Natl Acad Sci USA 1993 90: 2423–2427
Tian H, McKnight SL, Russell DW . Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells Genes Dev 1997 11: 72–82
Wiesener MS et al. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha Blood 1998 92: 2260–2268
Wickham TJ, Carrion ME, Kovesdi I . Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs Gene Therapy 1995 2: 750–756
Naldini L et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector Science 1996 272: 263–267
Andreesen R, Hennemann B, Krause SW . Adoptive immunotherapy of cancer using monocyte-derived macrophages: rationale, current status, and perspectives J Leukoc Biol 1998 64: 419–426
Brizel DM et al. Tumour hypoxia adversely affects the prognosis of carcinoma of the head and neck Int J Radiat Oncol Biol Phys 1997 38: 285–289
Bugelski PJ et al. Recruitment of exogenous macrophages into metastases at different stages of tumour growth Cancer Immunol Immunother 1987 24: 93–98
Bilbao G et al. Adenoviral/retroviral vector chimeras: a novel strategy to achieve high-efficiency stable transduction in vivo FASEB J 1997 11: 624–634
Firth JD, Ebert BL, Pugh CW, Ratcliffe PJ . Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer Proc Natl Acad Sci USA 1994 91: 6496–6500
Lowenstein PR, Enquist LW . Protocols for Gene Transfer in Neuroscience: Towards Gene Therapy of Neurological Disorders John Wiley: New York 1996
Acknowledgements
We thank T Hacker and R Roberts for histology and excellent technical assistance and R Harrison for administrative assistance. This project was supported in part by the Teaching Company Scheme, UK.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Griffiths, L., Binley, K., Iqball, S. et al. The macrophage – a novel system to deliver gene therapy to pathological hypoxia. Gene Ther 7, 255–262 (2000). https://doi.org/10.1038/sj.gt.3301058
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301058
Keywords
This article is cited by
-
Cell signaling activation and extracellular matrix remodeling underpin glioma tumor microenvironment heterogeneity and organization
Cellular Oncology (2023)
-
Hypoxic Macrophage-Derived VEGF Promotes Proliferation and Invasion of Gastric Cancer Cells
Digestive Diseases and Sciences (2019)
-
Hypoxia-inducible factor 1α is Essential for Macrophage-mediated Erythroblast Proliferation in Acute Friend Retrovirus Infection
Scientific Reports (2017)
-
Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment
Oncogene (2014)